Alone we can do so little, together we can do so much.

Frank earned his B.A. in Economics from Southern Methodist University and has led successful molecular diagnostic testing laboratories for 8 years, serving vast amounts of clients throughout North America. He is also the founder and CEO of the Gulfstream Companies (Gulfstream Health and Gulfstream Capital). Gulfstream’s focus is on opportunistic private debt and equity transactions, and its subsidiaries have deployed in excess of $400m of equity across 75+ investments throughout the United States. Gulfstream has a diverse asset base of passive and active investments focused in healthcare.

Dr. Ruben Bonilla-Guerrero’s interests include clinical pharmacology and genetics with a focus on pharmacogenomics. At GeneIQ he is responsible for the clinical content of genomic-based assays and leading the medical affairs team. Dr. Ruben Bonilla-Guerrero obtained his medical degree from the Universidad Veracruzana in Mexico. From there, he moved to the Mayo Clinic in Rochester Minnesota where he completed his training in Clinical Pharmacology and Clinical Biochemical Genetics, spending 14 years focusing on research and clinical laboratory medicine. Prior to working with GeneIQ, Dr. Bonilla-Guerrero spent nine years at Quest Diagnostics in both Laboratory Director and Medical Directors roles. Dr. Bonilla-Guerrero is board certified in Clinical Biochemical Genetics by the American Board of Clinical Pharmacology and American Board of Medical Genetics (ABMG) and in Molecular Biology by the American Society of Clinical Pathology (ASCP).

John is a veteran investor, advisor, board member and recognized executive in the Information Technology and Business Services Industries with more than 35 years of experience in CEO and senior leadership positions.  Earlier in his career, Harris spent twenty-five years with Electronic Data Systems (“EDS”), during which time he held a variety of executive leadership positions including Group Executive, Corporate Officer and President of EDS’ four strategic business units serving the telecommunication and media industries worldwide. In addition, John has served on numerous private and public board of directors as Chairman, Lead director, and Special Committee Chairman, as well as Chairing Audit, Compensation and Governance committees. Harris holds a Master of Business Administration and a Bachelor of Business Administration from the University of West Georgia and is on the Board of Advisors to the Richardson School of Business.

Samantha earned her B.S. in Microbiology from the University of Texas at Austin and is a certified Technologist in Molecular Biology from the American Society for Clinical Pathology. Samantha leads all corporate and laboratory operations ensuring the highest quality of service to clients.

Elena has more than 20 years of experience in Biology research and Biotechnology. In recent years, she worked at gene synthesis company Gen9 where she provided technical leadership to develop and optimize innovative methodologies for the automated production of DNA constructs. Elena also worked at Nanobiosym Diagnostics where she was involved in the development of diagnostic assays to detect infectious diseases such as Zika, Flu A/B, and HIV in human samples. At GeneIQ, Elena provides daily supervision of laboratory staff, oversees laboratory procedures, and coordinates workflow of routine laboratory tasks.